Clinical Trial Update: Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study of ENVARSUS in adult de-novo kidney transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Recipients
• Organ Transplant Complications

Drugs mentioned

• Envarsus (tacrolimus)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Organ or Tissue Transplant; Complications | Phase 4 | Status: COMPLETED